Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.natcopharma.co.in | |
Market Cap | 9,765.90 Cr. | |
Enterprise Value(EV) | 9,468.44 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 22.30 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 24.12 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 32.90 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 250.40 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 2.15 | Calculated using Price: 537.85 |
Dividend Yield | 0.84 | Period Ending 2022-03 |
No. of Shares Subscribed | 18.26 Cr. | 182,557,165 Shares |
FaceValue | 2 | |
Company Profile | ||
Natco Pharma is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). It is also engaged in contract manufacturing business, whereby it undertake selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products. It has diversified into the business of crop health sciences to leverage is skills in organic chemistry. |
1 Day |
|
+1.79% |
1 Week |
|
+0.44% |
1 Month |
|
-3.91% |
3 Month |
|
-10.95% |
6 Month |
|
-20.19% |
1 Year |
|
-39.12% |
2 Year |
|
-39.21% |
5 Year |
|
-45.95% |
10 Year |
|
+481.40% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 15.58 | 16.57 | 14.62 | 33.21 | 29.70 | 19.75 | 12.71 | 11.27 | 4.06 | |
Return on Capital Employed (%) | 18.02 | 15.62 | 18.04 | 39.21 | 35.28 | 23.71 | 14.82 | 13.99 | 4.86 | |
Return on Assets (%) | 8.62 | 10.10 | 9.72 | 23.43 | 23.05 | 16.02 | 10.30 | 9.43 | 3.43 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 726 | 846 | 1,296 | 1,649 | 3,072 | 3,489 | 3,774 | 4,122 | 4,264 | 4,571 | |
Non Curr. Liab. | 151 | 119 | 28 | 38 | 47 | 83 | 118 | 143 | 135 | 106 | |
Curr. Liab. | 312 | 414 | 493 | 627 | 592 | 729 | 685 | 526 | 710 | 401 | |
Minority Int. | 7 | 5 | 5 | 4 | 4 | 2 | 11 | 2 | |||
Equity & Liab. | 1,196 | 1,384 | 1,822 | 2,318 | 3,715 | 4,303 | 4,588 | 4,792 | 5,109 | 5,078 | |
Non Curr. Assets | 828 | 901 | 985 | 1,230 | 1,584 | 1,956 | 2,262 | 2,447 | 2,612 | 2,675 | |
Curr. Assets | 368 | 483 | 837 | 1,087 | 2,131 | 2,347 | 2,326 | 2,345 | 2,497 | 2,403 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 1,196 | 1,384 | 1,822 | 2,318 | 3,715 | 4,303 | 4,588 | 4,792 | 5,109 | 5,078 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 739 | 825 | 1,141 | 2,020 | 2,185 | 2,095 | 1,915 | 2,052 | 1,945 | 2,474 | |
Other Income | 17 | 15 | 10 | 14 | 40 | 130 | 107 | 106 | 99 | 99 | |
Total Income | 756 | 840 | 1,151 | 2,034 | 2,225 | 2,225 | 2,022 | 2,158 | 2,044 | 2,573 | |
Total Expenditure | -560 | -612 | -869 | -1,337 | -1,256 | -1,300 | -1,332 | -1,448 | -1,681 | -1,900 | |
PBIDT | 196 | 228 | 283 | 697 | 969 | 925 | 690 | 710 | 363 | 673 | |
Interest | -37 | -32 | -23 | -19 | -15 | -19 | -22 | -13 | -18 | -20 | |
Depreciation | -30 | -47 | -51 | -54 | -66 | -81 | -100 | -117 | -143 | -155 | |
Taxation | -31 | -4 | -53 | -140 | -192 | -182 | -111 | -137 | -32 | -90 | |
Exceptional Items | -15 | ||||||||||
PAT | 98 | 130 | 156 | 485 | 695 | 642 | 458 | 442 | 170 | 407 | |
Minority Interest | 5 | 4 | 1 | 1 | 1 | 2 | 3 | -2 | |||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 103 | 135 | 157 | 486 | 696 | 644 | 461 | 441 | 170 | 407 | |
Adjusted EPS | 6 | 8 | 9 | 28 | 38 | 35 | 25 | 24 | 9 | 22 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 61 | 144 | 93 | 112 | 346 | 464 | 669 | 417 | 299 | 47 | |
Cash Fr. Inv. | -107 | -109 | -115 | -176 | -299 | -1,116 | -612 | -167 | -103 | -5 | |
Cash Fr. Finan. | 26 | -35 | 29 | 154 | -48 | 651 | -51 | -251 | -186 | 35 | |
Net Change | -20 | 0 | 7 | 91 | -1 | -1 | 6 | -1 | 10 | 76 | |
Cash & Cash Eqvt | 10 | 10 | 12 | -74 | 24 | 22 | 28 | 20 | 26 | 111 |
Thu, 19 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate issue of duplicate share certificates |
Wed, 11 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Loss of Share Certificate |
Wed, 11 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended December 31 2022 |
Fri, 27 Jan 2023 |
|
|
|
|
|